San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas — Encinitas, California

San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas is a clinical research site located in Encinitas, California, United States 92024.

Crixeo Health Trust Score: 50/100 (POOR). This profile has not yet been claimed by the site owner.

San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas has participated in 4 clinical trials.

Therapeutic areas: Intraocular Melanoma, Melanoma (Skin), Brain and Central Nervous System Tumors.

Sponsors: San Diego Pacific Oncology & Hematology Associates.

Sponsor Feasibility Report

Trust Score: 50/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas?

San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas has a Crixeo Trust Score of 50/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas conducted?

San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas has 4 clinical trials on record. Their work covers Intraocular Melanoma, Melanoma (Skin), Brain and Central Nervous System Tumors.

Is San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas accredited by Crixeo Health?

San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.